Central adiposity carries an increased risk of non-insulin dependent diabetes mellitus (NIDDM), cardiac disease, hypertension and death, and is closely related to insulin resistance. Genetic factors explain a large proportion of the population variance in central adiposity, although the genotypic characteristics remain obscure. Hormonal factors such as endogenous sex steroid levels, the menopause, hormone replacement therapy and cortisol may in¯uence body fat partitioning. The link between dietary factors and central adiposity is controversial, with contradictory results in the literature. Smoking is associated with lower total body fat, but investigations of its in¯uence on central adiposity have also yielded contradictory results. Higher levels of physical activity are associated with lesser amounts of central fat, both cross-sectionally and in intervention studies. Some of the contradictory results regarding putative in¯uences on central adiposity may be due to limitations of some of the anthropometric parameters of central adiposity, such as the waist-hip ratio. Further research is required to clarify the relationships between many of these factors and with both compartments of central adiposity: subcutaneous abdominal and intraabdominal adipose tissue.
Introduction
The cost of obesity to society is considerable. Direct costs to the health system have been estimated at $US 68 billion 1 in the US alone for 1990. Indirect costs arising from functional impairment and disability are more dif®cult to estimate; where this has been assessed, in Finland for example, overweight contributed to a considerable proportion of disability pensions. 2 The major health risks of obesity, however, relate more to the distribution than to the amount of body fat. There is a strong relationship between central adiposity and insulin resistance, 3±7 both of which are integral to Syndrome X. 8 Central adiposity predicts the development of cardiovascular disease, 9±12 noninsulin dependent diabetes mellitus (NIDDM) 13, 14 and mortality ± the relative risk of death due to coronary disease was increased eight times in women with high waist-hip ratio (WHR). 15 WHR also predicted cardiac mortality in women, independent of body mass index (BMI) and cholesterol concentrations, at the 20 y follow-up of the Gothenburg Study. 16 
Measurement limitations
Before reviewing the in¯uences on central adiposity and body fat partitioning, it is necessary to consider the limitations of the anthropometric markers most commonly used. The traditional measure of WHR appears less accurate at indicating central fat mass than other simple measures, such as waist circumference and waist-height ratio. Studies using computerised tomography have shown both waist 17 and waist-height 18 have closer relationships with intraabdominal fat content than does WHR. We have con®rmed these ®ndings in healthy female twins, a subset of PHENOBASE TM , a proprietary database of Gemini Research Ltd, Cambridge, UK. This database comprises genotype and intermediate phenotype information on twin and affected sibship populations relating to complex trait disorders.
The data presented here were collected at St Thomas' Hospital, London. In 737 subjects, mean age ( AE s.d.) 56.7 AE 6.6 y and BMI 24.4 AE 3.9 kg/m 2 , central abdominal fat was measured with dual energy X-ray absorptiometry (DEXA), as described elsewhere. 19 The relationship between central abdominal fat mass and WHR (r 0.48, P`0.0001) was substantially weaker than that with waist circumference (r 0.82, P`0.001) and waist±height ratio (r 0.80, P`0.0001) (Figure 1 ). It may not be possible to extrapolate these data to other populations as, for example, intraabdominal fat volumes in obese AfroAmerican women differ from that of WHR-matched Caucasians. 20 There is a need for continuing assessment of these indices in different populations until the question of optimal measure is resolved. Optimal anthropometric measures for central adiposity may be population speci®c.
While anthropometry has limitations, the most accurate methods of measuring intraabdominal fat mass (magnetic resonance imaging and computerised tomography) may be impractical for large populations, costly and involve radiation exposure (CT). Both allow the accurate discrimination between components in central adiposity (intraabdominal and subcutaneous abdominal fat). DEXA, on the other hand, does not distinguish between these two sites, however the imperative to do so has been brought into question as subcutaneous abdominal fat relates closely to insulin resistance 5, 21 and is more metabolically active than gluteofemoral fat. 22, 23 The use of DEXA is practical for large populations, measures body fat content (total and regional) accurately though some subcutaneous abdominal fat is contained within the estimates of central body fat. 24 Further work is still needed in regard to the role of anthropometry in assessing body fat distribution in different populations and to de®ne the metabolic impact of the various components of central abdominal fat.
Determinants of central adiposity
The determinants of fat distribution are still only partially understood. Genetic in¯uences were ®rst suggested in a large family study, albeit using skinfolds. 25 Where central adiposity has been measured more directly, strong genetic effects have been reported ± they explain approximately 60% of the population variance in central fat in British 19 postmenopausal and Australian 26 premenopausal women. In both of these studies, there were genetic in¯uences on central adiposity which were independent of those on total fat. In the Quebec Family Study, an autosomal recessive locus explained 51% of the variance in abdominal visceral fat, but not after adjustment of central fat data for total fat. 27 Alteration in central fat stores, due to over-feeding 28 or to excess physical activity, 29 is also suggested to be predominantly under genetic control. In these studies, because only monozygotic twins were used, the possibility remains that environmental, rather than genetic, similarity contributed to the results.
In reviewing in¯uences of body fat distribution, it is important to note the regional differences in adipocyte metabolism. Differences in adipose accumulation are mostly attributable to regional differences in the quantity and activity of lipoprotein lipase (LPL), the key enzyme in the regulation of fatty acid deposition. 30 Gluteofemoral adipocytes are characterised by high LPL activity and low lipolytic activity. 22 In contrast, adipocytes in the central fat depot are distinguished by high lipolytic activity, 23 with rapid turnover of fatty acids, some of which drain portally and may contribute to insulin resistance. 31 The mechanisms of this differential regulation in lipolysis are unclear. The rate-limiting enzyme of the lipolytic cascade, hormone-sensitive lipase (HSL), is dependent on intracellular cAMP levels, regulated by the sympathetic nervous stimulation. 32 Regional differences in a2-adrenoreceptor concentration and activity 4 may partially explain the different rates of lipolysis, however the mechanisms of regional adrenergic regulation of HSL remain unclear.
32 Figure 1 Relationships of waist-hip ratio (WHR), waist circumference and waist-height ratio (WHTR) to central abdominal fat mass in 737 middle-aged women.
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Non-genetic in¯uences
Whilst genetic factors explain the majority of the population variance in central adiposity, non-genetic factors represent potentially important avenues for intervention and prevention in obesity management. The role of hormonal factors, diet, smoking and exercise will be discussed, while recognising that genetic factors also in¯uence ambient steroid levels.
Hormonal
Sex steroids: Regional fat deposition alters in women throughout their lives, revealing how alterations in sex steroids in¯uence energy partitioning. Oestrogen regulates LPL activity in gluteofemoral adipocytes (and thus fat deposition to this region). During the reproductive years in women, circulating lipid is preferentially deposited in the gluteofemoral region under the in¯uence of oestrogen. Together with low regional lipolysis rates, these contribute to the development of energy stores adequate for reproductive functions. Leptin produced by body fat stores may be a necessary signal for GnRH secretion and fertility. 33 In addition, maternal gluteofemoral stores provide a store of sustenance for the newborn ± the oestrogen-de®cient period following parturition is characterised by mobilisation of lipid from the gluteofemoral region 34 which, under the in¯uence of prolactin, is taken up by the breast for milk production.
The in¯uence of endogenous and exogenous sex steroids may also explain differences in fat partitioning prior to and following the menopause, in women with the polycystic ovary syndrome (PCOS) and male/ female sexual dimorphism. Males have more central adipose tissue than women and the polyphenotypic syndrome of PCOS is characterised by increased circulating testosterone, androstenedione and decreased sex hormone binding globulin (SHBG), accompanied by increased central fat and insulin resistance. 35 The sex steroid pro®le of obese women with predominantly central obesity also reveals higher testosterone levels and lower SHBG, in comparison to obese women with gluteofemoral fat distribution. 36 Genetic factors may play some role in determining ambient sex steroid levels. Exogenous administration of oestrogen in men (with prostatic carcinoma) resulted in increased gluteal adipocyte size, 37 whilst androgen administration to viscerally obese men reduced visceral fat. 38 With menopause-associated oestrogen de®ciency, fat deposition in the gluteofemoral region decreases LPL activity. 22 In contrast, aging males gradually accumulate central fat possibly in parallel with declining androgen levels, 39 though this may be confounded by accompanying decreases in physical activity.
Cross-sectional studies demonstrate age-and menopause-associated increases in central adiposity, using WHR 40 and DEXA or CT. 41±43 With less fat partitioned to the gluteofemoral region, the central abdominal region may act as a default repository, with adverse metabolic consequences. In our study of British twin women (derived from PHENOBASE TM ) we assessed the in¯uence of the menopause cross-sectionally using DEXA to measure total and central fat. The mean ( AE s 44 and was greater in premenopausal women (96.9 AE 36.5 vs 79.4 AE 31.9, P`0.0001) and strongly related to FFM (r 0.38, P`0.0001). In multiple regression models including age, menopausal status, use of hormone replacement therapy, smoking and physical activity, only physical activity (b 7 0.10, P 0.03) independently predicted central adiposity. The in¯uence of menopausal status and age may thus be less than that of activity, as has been found elsewhere. 40, 45 The menopause when observed longitudinally was characterised by an increase in fat mass and decrements in FFM, resting metabolic rate but also physical activity. 46 However, this and the other studies mentioned above cannot establish a causal relationship between oestrogen withdrawal and increased central adiposity, because of confounding by covariates such as activity.
Prospective studies of oestrogen replacement support a role of oestrogen in preventing central fat increments. For example, increases in central adiposity (assessed by DEXA) were attenuated in women receiving HRT compared to untreated women. 47 If gluteofemoral LPL activity and regional fat metabolism can be restored to premenopausal status by oestrogen replacement therapy, postmenopausal increases in central fat may be avoided. The possible prevention or attentuation of the enlargement of the central fat depot may explain some of the reduction in cardiovascular risk observed in women receiving oestrogen replacement.
Glucocorticoids: Cushing's syndrome is characterised by central obesity and cortisol excess. Dysregulation of neural and adrenal pathways governing cortisol secretion have been hypothesised to contribute to the development of central adiposity. 48 Chronic hypothalamic arousal due to maladaption, depression or dysphoria, associated with stressful social circumstances, smoking and alcohol consumption, are purported to result in increased activity in the CRF-ACTH-adrenal axis resulting in central adiposity. 48 Whilst an attractive hypothesis, several caveats are evident in the data: measures of central adiposity were restricted to WHR, investigations consisted of supraphysiological stimulation of neural-adrenal pathways. In addition, cortisol levels explain only a minor proportion of variance in central fat (by truncalabdominal skinfolds). 49 Finally, this hypothesis does not independently account for covariates such as social class and the association of behavioural factors (such as stress and depression) with alterations in alcohol intake, dietary pattern and physical activity. Whilst it is established that the central obesity that characterises Cushing's syndrome is associated with cortisol excess, the common central adiposity phenotype is distinguished by a lack of other features of Cushing's syndrome. Recent discoveries have revealed a complex network of interrelated neuroendocrine pathways involving, for example, leptin, neuropeptide Y, corticotrophin releasing factor and the sympathetic nervous system. As these intricate paths and their interconnections are clari®ed, any role of the corticosteroid axis in regulation should become clearer.
Behavioural
Dietary intake: The in¯uence of energy restriction on regional alterations in fat deposits has been investigated extensively. Numerous studies relying on anthropometric measures have yielded contradictory results. Several studies did not show a signi®cant decrease in WHR with weight loss. 50±53 This may be explained by limitations of WHR in re¯ecting changes in visceral fat, 52, 54 suggesting that WHR is not an appropriate tool for estimating central fat loss. 54 The amount of central fat loss occurring with weight reduction is in¯uenced by the size of the initial central fat depot 54, 55 and possibly by menopausal status, as substantial subcutaneous fat loss occurs in premenopausal obese women. 52 The role of dietary composition in the aetiology of overweight and obesity is controversial. The ®ndings of many studies are limited by selection bias, the measures of dietary intake and body fat, and the inclusion of energy underreporters. Prospective studies however, suggest that dietary fat intake may play a role in those genetically predisposed to obesity 56 and those already overweight. 57 Less is known about any relationship between dietary fat intake and central adiposity. Evidence suggesting a link is limited by indirect measures. 58, 59 Where central fat has been measured directly, no relationship between dietary fat and central fat was found. 60, 61 Whether there is such a relationship in genetically predisposed individuals has not been investigated.
Tobacco smoking: Cigarette smoking is a major risk factor for cardiovascular disease, 62 despite its association with a lower BMI and total adiposity. 63±67 It has been posited that smoking contributes to cardiovascular disease risk and insulin resistance through an effect on central adiposity, 65 possibly through increased androgen production. 68 An association between smoking and increased central adiposity is suggested by some, 63±67 but not all 69, 70 cross-sectional studies involving WHR. In our study of British postmenopausal twins, current smoking was associated with lower total body fat and lower central abdominal fat, using both waist circumference and direct measures. 71 Importantly, in identical twin pairs where only one twin smoked, when factors such as genes, age, menopausal status and HRT were controlled for, the smoking twin had lower central fat. 71 If smoking does not increase central fat, how does it exert its effects on insulin resistance and cardiovascular risk? Smoking stimulates the sympathetic nervous system, decreasing muscle blood¯ow and enhancing lipolysis, hence raising free fatty acids, 72 all of which may contribute to insulin resistance. Thus, the smoking-associated increase in cardiovascular risk may be effected through insulin resistance and increased sympathetic stimulation, distinct from any in¯uence on central adiposity. 70 Consistent with this, increased insulin resistance and dyslipidaemia are still present in smokers compared to controls when matched for BMI and WHR. 70, 73 Alcohol: The complex nature of the relationship between alcohol intake and fat distribution is illustrated by the number of con¯icting reports. In men, a direct relationship between alcohol intake and WHR has been reported. 66 In women, both direct 74 and inverse 66, 75 relationships have been reported. Where direct measures are used, alcohol intake was related to a lower central fat mass in women, in addition to total body fat. 60, 61 It has been suggested that certain social factors are collinear with alcohol consumption and may confound the relationship between alcohol and BMI. 76 Such factors, including socioeconomic status, education level and physical activity levels, may explain the disparity in results from studies of alcohol and central fat.
Physical activity: The increasing prevalence of obesity and related conditions has been accompanied, paradoxically, by decreased fat consumption in Western societies, but also a reduction in physical activity (where physical inactivity is implied by cars per family unit and hours of television watched). 77 In cross-sectional studies of normal populations, higher physical activity is associated with lower WHR. 66, 78, 79 In one study which followed a subgroup prospectively, changes in WHR were predicted by alterations in physical activity levels. 79 Cross-sectional or prospective population studies with direct measures are lacking.
The effect of exercise interventions on body composition have been reviewed in detail elsewhere.
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Central adiposity K Samaras and LV Campbell Exercise interventions have resulted in reductions in waist circumference 82 and truncal skinfolds 83 in men and women, and in intraabdominal fat measured by CT in women. 84, 85 Genetic factors as stated, may be responsible for the variance in response of central fat to exercise. 29 Regular physical activity may lower central adiposity by increasing immediate energy requirements which are met by body glycogen stores and increased fatty acids, the latter made more available by inverse effects of LPL activity in both muscle and adipose tissue. Fatty acid mobilisation occurs in response to the lipolytic stimuli that accompany moderate exercise including plasma catecholamine release and reductions in plasma insulin. 86 Central fat is the store most responsible to lipolytic stimuli and offers an immediate fuel source. Consistent with this, exercise-induced alterations in lipolytic activity are greater in abdominal, than in gluteofemoral, adipocytes. 87 In addition to the immediate effects of exercise on energy utilisation and lipid metabolism, longer term alterations in catecholamine-induced lipolysis occur with training, with appear to be due to increased hormone-sensitive lipase activation. 86 Exercise also diverts circulating fatty acids away from adipose stores by increasing LPL activity in muscle and decreasing it in fat, increasing fatty acid availability for fuel substrate.
Summary
Much needs to be clari®ed about the regulation of central fat. At present, it appears that there are strong genetic in¯uences, at least some of which are independent from those that affect total body fat mass. The hormonal milieu appears important, as perturbations in sex steroid are associated with alterations in the fat distribution typical to men and women. Alterations in energy balance, such as energy restriction and increased physical activity, are associated with reductions in central fat mass and may ameliorate the metabolic consequences associated with central obesity. The exquisite sensitivity of some individuals to certain environmental factors requires further investigation. As such, gene-environment interactions are suggested for individuals genetically predisposed to obesity and dietary fat. 56 Whether other gene-environment interactions also exist is not presently known, though understanding this would enable more targeted, therapeutic and ef®cient interventions.
